Eli Lilly said on Tuesday it was collaborating with Nvidia to build a supercomputer to help with drug discovery and shorten ...

Somehow, it’s becoming even harder to get a GLP-1.

Health-care companies fell as traders rotated out of the sector. The SPDR Select Sector Health Care exchange-traded fund, which tracks the health-care industry group of the S&P 500, fell 0.6%, paring ...

Eli Lilly partners with Nvidia to build the pharma industry’s most powerful AI supercomputer, aiming to speed up drug discovery and innovation.

Drug company Eli Lilly and NVIDIA announced a new partnership to build a supercomputer for drug research. Drug manufacturer ...

Nvidia shares picked up strength in afternoon trading, rising 5.5% and pushing the AI chip giant's market value above $4.9 trillion for the first time, according to Dow Jones Market Data. Behind the ...

Eli Lilly and computing giant Nvidia are teaming up to build a new supercomputer that the pair say will be the most powerful owned and operated by a pharmaceutical company.

New AI capabilities will help scientists identify, optimize and validate new molecules Additional applications include manufacturing, medical imaging and ...

Eli Lilly announced a partnership with chipmaker NVIDIA to build what it claims will be the “most powerful supercomputer ...

In advance of CPhI, Cambrex and Wilmington PharmaTech both just announced big investments in US plants that make active ...

It's the latest stride by Nvidia and the pharmaceutical industry to harness AI to try to reduce costs and shorten the time it ...

Nvidia announced on Tuesday that drugmaker Lilly is developing an AI system using more than 1,000 Blackwell Ultra chips.